[ad_1] Reviewed by Emily Henderson, B.Sc.October 28, 2020 Dementia and other cognitive impairments now appear to be risk factors for developing severe COVID-19, according to research from the University of Georgia. The findings highlight the need for special care for populations with these pre-existing conditions during the pandemic. In a …
Read More »Genetic analysis with RNA sequencing can increase diagnostic yield, the study shows
[ad_1] Reviewed by Emily Henderson, B.Sc.October 28, 2020 In the world of rare genetic diseases, exome and genome sequencing are two powerful tools used to make a diagnosis. A recent addition to the toolkit, RNA sequencing, has been shown to help researchers narrow down the candidate disease variants first identified …
Read More »The study investigates the link between clonal hematopoiesis and treatment-related blood cancer risk
[ad_1] Reviewed by Emily Henderson, B.Sc.October 27, 2020 In recent years, improvements in cancer therapy have led to a significant increase in cancer survival. Experts estimate that by 2022 the United States will have 18 million cancer survivors, but a subset of these survivors will have long-term health problems to …
Read More »Genetic Technologies Limited announces a new Blockchain biochemical joint venture
[ad_2][ad_1] MELBOURNE, Australia, 20 December 2018 (GLOBE NEWSWIRE) – Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company"), through its subsidiary Gene Ventures Pty Ltd, is pleased to announce that it has joint venture with Blockshine Technology Corporation (BTC). The joint venture (JV), called Blockshine Health, will pursue and develop blockchain …
Read More »Genetic Technologies Limited announces a new Blockchain biochemical joint venture
[ad_2][ad_1] MELBOURNE, Australia, 20 December 2018 (GLOBE NEWSWIRE) – Genetic Technologies Limited (ASX: GTG, NASDAQ: GENE, "Company"), through its subsidiary Gene Ventures Pty Ltd, is pleased to announce that it has joint venture with Blockshine Technology Corporation (BTC). The joint venture (JV), called Blockshine Health, will pursue and develop blockchain …
Read More »Macrogen develops the Blockchain platform to share genetic data
[ad_2][ad_1] Rapid advances in genetic sequencing have opened up new opportunities for many companies. Blockchain could be the technology that allows you to share genetic information safely around the planet. The South Korean company Macrogen recently announced that it would work with Bigster to develop a platform for sharing genetic …
Read More »Biotech Giant plans to securely share genetic data on a Blockchain
[ad_2][ad_1] A listed biotech giant based in South Korea is turning to the blockchain to allow it to share genetic data without the risk of hacking or violating patient privacy. Macrogen, a Seoul-based DNA sequencing service provider, said in a press release on Monday that it is working with Bigster, …
Read More »